Non-alcoholic fatty liver and cardiovascular disease: an emerging relationship.
Baou
Katerina
K
Peripheral Vessels Unit, First Cardiology Department, Athens Medical School, Hippokration General Hospital, Athens, Greece.
Vlachopoulos
Charalambos
C
Manesis
Emanuel
E
Archimandritis
Athanasios
A
Stefanadis
Christodoulos
C
D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D050197:Atherosclerosis / Q000201:enzymology / Q000453:epidemiology* / Q000503:physiopathology*; D002318:Cardiovascular Diseases / Q000201:enzymology / Q000209:etiology* / Q000503:physiopathology; D015897:Comorbidity; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology; D018450:Disease Progression; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D005234:Fatty Liver / Q000201:enzymology / Q000453:epidemiology* / Q000503:physiopathology; D006801:Humans; D006973:Hypertension / Q000453:epidemiology; D008103:Liver Cirrhosis / Q000201:enzymology / Q000453:epidemiology / Q000503:physiopathology; D008111:Liver Function Tests; D024821:Metabolic Syndrome / Q000453:epidemiology
D005230:Fatty Acids, Nonesterified; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase